Welcome to the Austrian page of the ESCP

Austria is an old country and dates back to the time of the Roman Empire. In the past centuries there were some outstanding Austrian doctors like Julius Wagner-Jauregg (noble prize winner 1927), Karl Landsteiner (noble prize winner 1930) and Ignaz Semmelweiss. The most famous surgeon was Theodor Billroth who is well known and stands for the founder of modern abdominal surgery.

The Austrian section of colorectal surgeons and proctologists (ACP-Arbeitsgemeinschaft für Coloproktologie http://www.coloproctology.info) was founded in 1995 and is a part of the Austrian Society of Surgery (http://www.chirurgie-ges.at). Every year there is a winter meeting which is organized by this section of the society. The main topic is proctology with special courses for different pathologies. Another organisation located in Vienna is the European Federation for Colorectal Cancer (EFR). Every two years the EFR is organizing an international congress in Vienna. The 10th International EFR Congress took place from 20.04. to 22.04.2017 at the Medical University of Vienna. (https://www.efrcancer.org)

Population: 8,770,000
ESCP Members: 17
Society: Austrian Society of Surgery, Austrian Society of Surgical Oncology
ESCP Representative Name: Martina Lemmerer
National Examination: General Surgery including Coloproctology (https://www.arztakademie.at/pruefungen)
Journal(s): European Surgery (https://link.springer.com/journal/10353)

Achievements:

The ABCSG Trial R02 demonstrated that preoperative chemoradiation with capecitabine and oxaliplatin is feasible in patients with MRI-proven cT3 LARC. The only clinically relevant toxicity was diarrhea. Overall, efficacy of the multimodality treatment was good, but not markedly exceeding that of 5-FU- or capecitabine-based chemoradiation approaches.

The APC is organizing different courses in proctology eg. “Pelvic floor anatomy and disorder” and “Surgical techniques in proctology” (http://www.coloproctology.info) A consensus paper was published how to treat hemorrhoids and how to treat the anal infection by human papillomavirus (HPV).

Current Research:

- Assessment of quality of life and health status in IBD patients with anal fistulas. - TNF antibody therapy in IBD patients after bowel resection. Most studies are organized by the ABCSG - Austrian Breast and Colorectal Cancer Study Group (http://www.abcsg.at). A forthcoming study will be “Endurance training in patients after colorectal cancer to prevent recurrence”.

Future Plans:

The new established Comprehensive Cancer Center Vienna which is located at the Medical University of Vienna, the Comprehensive Cancer Center Graz at the Medical University of Graz and the Comprehensive Cancer Center Innsbruck will focus on different tumors including colorectal  an anal cancer. The aim of these centers are not only to perform clinical trials but also basic science and programs for specific surgical and oncological trainee.

The ACP provides special training for coloproctology and now offers a national education training program for colorectal fellows.

The training program an certificate enables interested colleagues to undertake a structured and specialized training in coloproctology and to confirm this with a certificate which gives an access qualification to the EBSQ Coloproctology examination. The specialization in coloproctology should cover a minimum of 3 years. The training is divided into several theoretical and practical sessions which can be individually organized at the Medical University Innsbruck Vienna and Graz. (http://www.coloproctology.info/index.php/de/ausbildungspass)

ESCP Affiliates